The company’s mainstay drugs are treatments for multiple sclerosis, a group under increased threat since Roche Holding entered the market last month with Ocrevus. Though Biogen is entitled to a share of Ocrevus sales through a royalty agreement, analysts worry that may not be enough to make up for its loss of market share and diminished ability to raise prices. Ocrevus is most likely to hit sales of Biogen’s drug Tysabri, Chief Financial Officer Paul Clancy said on a conference call, and could also hurt sales of the company’s top drug, the multiple sclerosis pill Tecfidera. Biogen’s multiple sclerosis drugs bested expectations for the quarter, helped by $545 million in sales of the Tysabri injection that beat analysts’ average estimate of $481 million. The CEO has promised to boost sales by focusing on Spinraza and creating ways to keep patients on the company’s lead product, Tecfidera. Spinraza, developed in partnership with Ionis Pharmaceuticals Inc., has proved an unexpected windfall to Biogen, dashing from late-stage trials to U.S.

BING NEWS:
  • Hershey Beats Earnings Estimates as Sales in North America Jump
    Earnings, Revenue Beat Analysts' Estimates The maker of Hershey ... maintaining its projection of a 2% to 3% increase in sales and unchanged adjusted EPS from 2023. Hershey shares were little changed ...
    05/2/2024 - 1:00 pm | View Link
  • Informatica logs earnings beat, following acquisition flirtation with Salesforce
    Informatica, which has been linked to a potential acquisition by Salesforce Inc. CRM, -0.09% that fell through, provided second-quarter sales guidance of $394 million to $410 million. FactSet analysts ...
    05/1/2024 - 10:05 am | View Link
  • Amazon earnings results: AMZN stock rallies after hours from AI-fueled AWS growth, Q1 sales and profit beats
    Amazon reported quarterly earnings today, April 30, beating sales and revenue projections. AMZN shares rose 3% in after-hours trading.
    04/30/2024 - 11:03 am | View Link
  • Super Micro Shares Dip On Mixed Q3 Results: EPS Beat, Sales Miss
    Super Micro Computer reported quarterly earnings of $6.65 per share which beat the analyst consensus estimate of $5.78 by 15.05% and represents a 307.98% increase over earnings of $1.63 per share from ...
    04/30/2024 - 9:50 am | View Link
  • Amazon Q1 Earnings Highlights: Revenue Beat, EPS Beat, AWS Hits $100-Billion Annual Run Rate And More
    Amazon.com reported first-quarter financial results Tuesday. A look at the key highlights and breakdowns of AWS, Prime Video and more.
    04/30/2024 - 9:22 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News